Stroke Program

Share this

Overview

Stroke, now also known as "Brain Attack" and transient ischemic attack (TIA) is a complex injury to the central nervous system that originates in inadequate blood supply to the brain. They are treated by the team of specialists in the UCLA Stroke Program.

UCLA Stroke Program is a world leader for the diagnosis, treatment and management of this type of vascular diseases of the brain and spinal cord.

UCLA neurovascular surgeons collaborated with colleagues in diagnostic neuroradiology, interventional neuroradiology, stroke neurology, neurological critical care, and neurological rehabilitation to treat thousands of patients over the last 15 years.

Clinicians and researchers are integral part of the UCLA Stroke Center, the first in Los Angeles County certified by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) as a Primary Stroke Center.

As part of an academic center of excellence, the program offers opportunities for patients to participate in cutting-edge treatments sponsored by the National Institutes of Health. The neurovascular team is constantly analyzing results to improve outcomes and works tirelessly to provide the very best quality of care.

Features

The UCLA team has developed a number of state-of-the-art treatments for neurovascular patients.

The MERCI clot-retrieval device was designed at UCLA and recently approved by the Food and Drug Administration for restoration of cerebral blood flow following a cerebrovascular event.

UCLA was the first center in the United States to participate in a randomized, controlled trial of carotid and vertebral artery angioplasty. Additional trials of combined angioplasty and stenting are ongoing.